| 2.57 Data as of 3:59pm ET |  +0.07 / +2.80%Today’s Change | 1.49 Today|||52-Week Range 4.70 | +56.71% Year-to-Date |
| Previous close | 2.50 |
| Today’s open | 2.60 |
| Day’s range | 2.53 - 2.63 |
| Volume | 33,784 |
| Average volume (3 months) | 74,029 |
| Market cap | $53.0M |
| Dividend yield | -- |
| Earnings growth (last year) | +45.00% |
| Earnings growth (this year) | +18.18% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 33.76 |
| Price/Book | 2.92 |
| Today’s change | Today’s % change | |
|---|---|---|
| CMXICytomedix Inc | -0.04 | -8.16% |
| SVNTSavient Pharmaceutic... | -0.01 | -1.79% |
| TSPTTranscept Pharmaceut... | +0.06 | +2.03% |
| ORMPOramed Pharmaceutica... | -0.55 | -7.91% |
| Next reporting date | August 16, 2013 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $802.6K |
| Annual profit (last year) | -$11.0M |
| Net profit margin | -1,365.76% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Yuichi Iwaki, MD, PhD |
Chief Financial & Accounting Officer Michael J. Gennaro, MBA, CPA |
Corporate headquarters San Diego, California |
.
